Ultragenyx Pharmaceutical

About Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Explore similar firms in the Biotechnology

Email Format

{first_letter_first_name}{last_name}@ultragenyx.com — 83.3%

ssmith@ultragenyx.com

{first_name}@ultragenyx.com — 16.7%

sarah@ultragenyx.com

Key Employees

Contact details of 15 Ultragenyx Pharmaceutical executives

John Klock

Founder
  • Work email

    j**n@ultragenyx.com

Jung Cho

Associate Director of Validation
  • Work email

    j**o@ultragenyx.com

Akhilesh Bhambhani

Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops
  • Work email

    a********i@ultragenyx.com

Marisa Capponi

Associate Director
  • Work email

    m******i@ultragenyx.com

Benjamin Ehrhart

Vice President, Assistant General Counsel
  • Work email

    b******t@ultragenyx.com

Kenneth Lowe

Director

Howard Horn

Executive Vice President and CFO

John Pinion

EVP Translational Sciences, Chief Quality Operations Officer

Dennis Huang

Chief Technical Operations Officer; EVP Gene Therapy Operations

Emil D. Kakkis

Founder

Devan Krishnamoorthi

CIO & Senior Vice President

Kathleen McKeever

Senior Vice President

Arjun Natesan

Senior Vice President

Binodh DeSilva

Senior Vice President

Wenchi Liu

Senior Vice President, Legal

Other Employees

Contact details of 4 Ultragenyx Pharmaceutical other employees

Xiaohui Lu

Senior Research Scientist
  • Work email

    x*u@ultragenyx.com

Yael Weiss

VP Business Development,Executive Director, Search and Evaluation, Business Development

Christine Murray

Senior Advisor, Development

Carolyn Wang

SVP, Global Corporate Communications

General Emails

General company emails, e.g. customer support lines

    info@ultragenyx.com

    General Inquiries

    trialrecruitment@ultragenyx.com

    Unclassified inbox

    MCorley@ultragenyx.com

    Unclassified inbox

    higair@ultragenyx.com

    Investor Relations

    blakemedia@ultragenyx.com

    Media Relations

    ekakkis@ultragenyx.com

    Unclassified inbox

    gcapiaux@ultragenyx.com

    Unclassified inbox

    mwhetstone@ultragenyx.com

    Unclassified inbox

Similar Companies like Ultragenyx Pharmaceutical

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics Medical Devices Hospitals & Clinics

Legal Name: Medtronic, plc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

Company Info

Last updated: 27/07/2025

+1 415 483 8800

Novato, California, United States

Ultragenyx Pharmaceutical General Information

Specialization: Biotechnology, Healthcare & Medical, Pharmaceuticals
Legal Name: Ultragenyx Pharmaceutical Inc.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +1 415 483 8800
Last Investment Activity: Feb 26, 2024
Investments Activity: Feb 26, 2024 Jan 9, 2024 Nov 3, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.